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Background: The purpose of the current study is to assess which vertical bone augmentation tech-
niques are most effective for restoring atrophic posterior areas of the mandible with dental implants
and compare these procedures with alternative treatments.
Methods: Electronic literature searches in PubMed (MEDLINE), Ovid, and the Cochrane Library were
conducted to identify all relevant articles published up to July 1, 2015. Eligibility was based on inclusion
criteria, and quality assessments were conducted. The primary outcome variables were implant and pros-
thetic failure. After data extraction, meta-analyses were performed.
Results: Out of 527 potentially eligible papers, 14 randomized clinical trials were included. Out of
these 14 studies, four trials assessed short implants (5 to 8 mm) as an alternative to vertical bone aug-
mentation in sites with a residual ridge height of 5 to 8 mm. No statistically significant differences were
found in implant (odds ratio [OR]: 1.02; 95% confidence interval [CI]: 0.31 to 3.31; P = 0.98; I2: 0%) or
prosthetic failure (OR: 0.64; 95% CI: 0.21 to 1.96; P = 0.43; I2: 0%) after 12 months of loading. However,
complications at treated sites increased with the augmentation procedures (OR: 8.33; 95% CI: 3.85 to
20.0; P <0.001; I 2: 0%). There was no evidence of any vertical augmentation procedure being of greater
benefit than any other for the primary outcomes (implant and prosthetic failure).
Conclusions: Short implants in the posterior area of the mandible seem to be preferable to vertical
augmentation procedures, which present similar implant and prosthetic failure rates but greater morbid-
ity. All the vertical augmentation technique comparisons showed similar intergroup results. J Periodontol
2016;87:1444-1457.
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S
ince Bra˚nemark et al.1 defined osseointegra-
tion in the mid-1960s, oral rehabilitation with
dental implants has become a common prac-
tice, with reliable and safe long-term results.2 However,
presence of an adequate bone volume is mandatory to
achieve optimum treatment outcomes.3 Lack of suffi-
cient bone height to place dental implants in the pos-
terior mandible due to the presence of the inferior
alveolar nerve is a common scenario in partially eden-
tulous patients. Hence, an atrophic posterior mandible
presents a great challenge for successful rehabilitation.4
Although removable partial dentures are the most
common and simplest option, many patients seek
fixed prosthesis treatment. However, atrophy pre-
cludes use of standard size implants in many cases.
As a result, several surgical procedures have been
proposed to rehabilitate these patients with fixed
implant-supported prostheses.4-6
Vertical bone augmentation techniques using guided
bone regeneration (GBR),7-14 alveolar distraction os-
teogenesis,3,15-21 interpositional block grafts,19,22-30 or
onlay bone grafting20,29,31-35 have shown favorable
outcomes, both clinically and histologically.4 However,
these procedures cannot be considered the standard of
care due to the high rate of postoperative complica-
tions. Also, information on long-term results (‡10 years
of follow-up) is scarce.5
Use of short implants may be considered an alter-
native to reduce treatment time, costs, and morbidity,
and to increase feasibility of treatment by general
practitioners.5,24-27,31 Although there is still no con-
sensus regarding the cutoff length between short and
standard implants,36,37 Renouard andNisand38 defined
short implants as devices with an intrabony length of
8 mm or less. Several studies have reported successful
outcomes in terms of implant and prosthetic survival as
well as implant success rates in short-term follow-
ups.5,39,40 Nevertheless, there are still concerns re-
garding consequences of peri-implant bone loss and its
impact on long-term success rate. Also, placement of
short implants requires a certain amount of bone above
the mandibular canal, which is not always available.
Inferior alveolar nerve lateralization or transposition
has been suggested as an alternative to augmentation
procedures, allowing simultaneous insertion of stan-
dard implants without minimum bone height require-
ments.41-45 However, both temporary and permanent
neurosensory dysfunction as well as mandibular
fractures may occur postoperatively and overshadow
the high survival rates reported.44,45
Although two meta-analyses have been published
on this topic, in 20095 and 2014,40 they did not in-
clude some well-designed recently published trials.
Furthermore, one of these reviews40 also analyzed
the outcomes of implants placed in the maxilla. Thus,
a new meta-analysis of randomized controlled trials
centered exclusively on the posterior mandible may
add new information.
Aims of the present study are to analyze all rele-
vant data from randomized clinical trials (RCTs), to
assess which vertical bone augmentation techniques
are most effective for restoring atrophic posterior
areas of the mandible with dental implants, and to
compare vertical bone augmentation procedures
with alternative treatments.
MATERIALS AND METHODS
This meta-analysis complies with the Quality of Re-
porting of Meta-Analyses Statement.46
Study Selection Criteria
Inclusion criteria were: 1) RCTs (including split-mouth
designs) that considered the effect of two different
vertical bone augmentation procedures, or two different
biomaterials for the same vertical bone augmentation
technique, on the outcome of atrophic posterior
mandible implant rehabilitation; and 2) RCTs (in-
cluding split-mouth designs) comparing vertical bone
augmentation with alternative surgical treatments,
such as short implants (length £8 mm38) or inferior
alveolar nerve transposition/lateralization.
Table 1.
Issues of Interest by Study Population (P),
Intervention (I), Control Group (C), and
Outcome (O) (PICO factors)
Parameter Issues of Interest
Population Healthy partially edentulous patients with
vertical atrophy of the posterior
mandibular region who may require
alveolar bone augmentation prior to or
during dental implant placement
procedures
Intervention GBR
Interpositional bone graft (inlay)
Onlay block graft
Alveolar distraction osteogenesis
Control Other vertical augmentation procedures
(e.g., short implants [£8 mm length] and
inferior alveolar nerve transposition/
lateralization)
Other biomaterials
Outcome Implant and prosthesis survival rate
Major postoperative complications rate
Augmentation procedure failure
Biologic and prosthetic complications rate
Radiographic bone gain
Radiographic MBL
Patient preference
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The posterior area of the mandible was classified as
atrophic when bone height from the alveolar crest to the
inferior alveolar nerve canal did not allow placement of
standard length dental implants (length >8 mm).
The present review excluded trials with <1 year of
follow-up after loading the implant-supported pros-
thesis. Implant placement, abutment connection, and
yearly follow-up visits after prosthetic loading were
used as time points. The predefined study population,
intervention, control group, and outcome parameters
for eligibility of studies are summarized in Table 1.
Primary outcome measures were as follows: 1) Im-
plant survival: biologic failures were defined as implant
mobility or removal of stable implants caused by pro-
gressive marginal bone loss (MBL) or infection. Me-
chanical failures were considered to comprise any
mechanical complication, such as implant fractures or
platform deformations, which rendered the implant
unusable. Biologic failures were classified as early
(failure to establish osseointegration before prosthetic
loading) or late (failure to maintain the established os-
seointegration).8 2) Prosthesis survival: prosthetic fail-
ures were defined as failure to position the planned
prosthesis due to implant failure(s) or loss of the
prosthesis secondary to implant failure(s).8
Secondary outcome measures were as follows: 1)
postoperative complications at augmented and/or do-
nor sites (e.g., infection, nerve injury, hemorrhage)
before prosthetic loading; 2) augmentation procedure
failure: inability to position implants planned, not af-
fecting survival of implant actually inserted; 3) biologic
complications: implant function disturbances charac-
terized by involvement of supporting tissues (e.g., peri-
implantitis); 4) technical complications: mechanical
damage to implants, implant components, and/or su-
prastructures (e.g., fractures of implants, screws, or
abutments, fractures or deformations of the framework
or veneers, or screw or abutment loosening); 5) radio-
graphic bone gain (expressed in mm or as a percent-
age); 6) radiographic peri-implant MBL: marginal bone
level changes over time, from baseline to last follow-up
appointment (expressed inmmor as a percentage); and
7) patient preference (only in split-mouth trials).
Search Strategy
An electronic search of PubMed (MEDLINE), Ovid,
and the Cochrane Library databases up to July 1,
2015 was conducted to identify all relevant human
RCTs without year or language restrictions.
The following search terms were applied: [(vertical
bone augmentation OR vertical ridge augmentation OR
vertical ridge regeneration OR vertical bone regener-
ation OR guided bone regeneration OR bone graft OR
block graft OR interpositional bone graft OR distraction
osteogenesis) AND (‘‘Dental Implants’’[Mesh] OR short
dental implants OR inferior alveolar nerve lateralization
OR inferior alveolar nerve transposition) AND posterior
mandible].
The search was completed by manual screening of
references cited in the selected articles and reviews.
Selection of Studies
Two examiners (OC-F and GB-B) independently
selected studies in accordance with inclusion criteria.
Any disagreements were resolved by consensus.
Initially, duplicates or irrelevant publications (based
on title) were excluded, and abstracts were examined.
Finally, full texts of all remaining papers were as-
sessed. Studies removed at this stage and reasons for
their exclusion were recorded.
When multiple reports on the same patients were
identified, the publication with the longest follow-up
was included.
Data Extraction and Method of Analysis
Two reviewers (OC-F and GB-B) independently
extracted data using data-extraction tables. Whenever
possible, the following data were retrieved from the
selected papers: 1) author(s); 2) year of publication;
3) country of origin; 4) study design; and 5) details of
participants, intervention(s), and outcomes.
Implant and prosthesis survival rates were considered
primary outcome variables. Secondary outcomes com-
prised: 1) major postoperative complication rate; 2)
augmentation procedure failure rate; 3) mean radio-
graphic bone gain; 4) MBL; and 5) patient preference.
Risk of Bias Assessment
Two reviewers (OC-F and GB-B) independently as-
sessed risk of bias of the RCTs included as part of the
data extraction process, using the Cochrane Collabo-
ration tool for assessing risk of bias, suggested in the
Cochrane Handbook for Systematic Reviews of In-
terventions (version 5.1.0).47 The following items were
evaluated: 1) sequence generation; 2) allocation
concealment; 3) examiner and patient masking; 4)
outcome masking; 5) incomplete outcome data ad-
dressed; 6) selective reporting; and 7) other sources of
bias, such as conflict of interest. Publications were
grouped into the following categories:5 A) low risk of
bias (possible bias not seriously affecting results) if all
criteria were met; B) high risk of bias (possible bias
seriously weakening reliability of results) if one or more
criteria were not met; C) unclear risk of bias when too
few details were available for classification as high or
low risk. Authors were contacted for clarification of
missing or unclear information when necessary.
Statistical Analyses
Statistical analysis was carried out with statistical
software.†† For dichotomous outcomes, odds ratios
†† Review Manager v.5.3, The Cochrane Collaboration, Copenhagen,
Denmark.
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(ORs) with 95% confidence intervals (CIs) were used
to estimate effect of an intervention. Parametric and
non-parametric tests (Pearson x2, Fisher, and Mann–
Whitney tests) were used to compare groups. For
continuous outcomes, mean differences and stan-
dard deviations (SDs) were used to summarize data
for each group. The level of significance was set at
a P value <0.05.
In parallel group studies, the statistical unit was the
patient, not the augmentation procedure or implants.
In split-mouth designs, augmentation procedures
or prostheses used in each pair were the unit of
analysis.48
A meta-analysis was only performed when there
were studies comparing similar techniques and re-
porting the same outcome measures. ORs and mean
differences were combined for dichotomous and
continuous data, respectively, using random-effects
models. Data from split-mouth studies were com-
bined with data from parallel group trials using the
generic inverse variance method.49
Statistical heterogeneity was
estimated by means of x2 (Q
value) and I2 analyses. A x2
P value of <0.05 and an I2 value of
>50% were interpreted as signifi-
cant heterogeneity.50
Had there been a sufficient
number of meta-analyzed trials
(more than 10), publication bias
and clinical heterogeneity assess-
ment, as well as sensitivity ana-
lyses, would have been performed
according to Higgins and Green.47
RESULTS
Study Selection and
Description
The initial electronic database
search yielded 527 references, and
three additional papers26,27,34 were
included after hand searching ref-
erence lists for pertinent articles
and reviews. After duplicate re-
moval and assessment of both title
and abstract, a total of 26 articles
were eligible for full-text analysis.
Reviewer agreement was 95.2%,
with a k index of 0.90 (almost
perfect agreement).
Twelve publications were ex-
cluded after applying study criteria:
seven were removed as more re-
cent data were available;51-57 two
trials were excluded as the follow-
up after prosthetic loading was <1
year;58,59 and another three papers were rejected
because of retrospective design,31 absence of a con-
trol group,35 and not presenting vertical bone aug-
mentation procedures,60 respectively.
Finally, 14 RCTs fulfilled the inclusion criteria and
were selected for qualitative synthesis (Table 2).3,11-
13,19,20,24-30,34 As four of these compared short im-
plants to implants placed in vertically augmented
bone by means of interpositional block xenografts,
a meta-analysis of their results at 12 months after
prosthetic loading was conducted.24-27
A flowchart of the screening process is shown in
Figure 1.
Risk of Bias Assessment
All studies included were considered to have a high risk
of participant and clinician/researcher masking bias
due to difficulties in masking the selected treatment.61
Hence, results of the present systematic review and
meta-analysis should be interpreted with caution. Fig-
ure 2 summarizes the quality of RCTs included.
Figure 1.
Flowchart illustrating the study selection process.
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Extraction Data
Qualitative synthesis. The fourteen studies selected
comprised 276 patients, of whom 18 could not be
analyzed due to dropout within the follow-up period
(weighted mean dropout rate: 2.9%) (Table 3).3,11-
13,19,20,24-30,34
None of the studies revealed significant differences
between groups in terms of implant and prosthesis failure
rates (P >0.05).
One hundred eight postoperative complications
were reported in 243 vertical augmentation procedures
(weighted mean postoperative complication rate:
44.4%; range: 8.3% to 89.5%) (Table 3). The most
common complications were transient paraesthesia of
the mental nerve (62.0%), surgical wound dehiscence
(15.7%), and postoperative infections (13.9%). None of
the studies revealed significant differences among
groups (P >0.05) (Table 3).3,11-13,19,20,24-30,34
Fourteen postoperative complications were re-
ported in 76 patients who received short dental im-
plants (weighted mean postoperative complication
rate: 18.4%; range: 0% to 42.1%). The most common
complication was transient paraesthesia of the mental
nerve (92.9%).24-27 Of the four studies comparing
short implants with augmentation procedures, three
trials showed significantly more complications in the
grafted group.25-27
In one trial, distraction osteogenesis showed a sig-
nificantly higher bone gain than an autogenous inlay
graft (10.4 versus 4.3 mm; P <0.01).19
Peri-implant MBL was registered in both groups in
all of the studies. Autogenous onlay grafts were
significantly associated with higher MBL than inlay
grafts (2.9 versus 0.7 mm; P <0.01).29 Additionally,
two papers reported statistically significantly less
bone loss around short implants.25,26
Quantitative synthesis. The four trials meta-
analyzed involved a total of 135 patients.24-27 Two had
a split-mouth design.24,27 Consequently, 85 patients
were treated with short dental implants (test group)
and 85 patients were reconstructed with interpositional
block xenografts covered with a resorbable membrane
to receive long implants (control group).
No statistically significant differences were found
in: 1) implant failure (OR: 1.02; 95% CI: 0.31 to 3.31;
P = 0.98; I2: 0%) (Fig. 3A); 2) prosthetic failure (OR:
0.64; 95%CI: 0.21 to 1.96; P = 0.43; I 2: 0%) (Fig. 3B);
3) biologic complications (OR: 3.12; 95% CI: 0.12 to
85.21; P = 0.49; I 2: not applicable) (see supple-
mentary Figure 1 in online Journal of Periodontol-
ogy); 4) technical complications (OR: 3.12; 95% CI:
0.12 to 85.21; P = 0.49; I2: not applicable) (see
supplementary Figure 2 in online Journal of Peri-
odontology); 5) patient preference (OR: 32.43;
95% CI: 0.02 to 42211.19; P = 0.34; I 2: 90%) (see
supplementary Figure 3 in online Journal of
Figure 2.
Risk of bias assessment of selected studies. + = low risk of bias; - =
high risk of bias; ? = unclear risk of bias.
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Periodontology); or 6) peri-implant
MBL (mean difference: -0.03 mm;
95% CI: -0.11 to 0.05; P = 0.44; I2:
53%) (see supplementary Figure 4 in
online Journal of Periodontology)
after 12 months of prosthetic load-
ing. However, augmentation groups
were associated with an increased
rate of postoperative complications
(56 out of 85 patients) compared
with short implant groups (18 out of
85 patients) (OR: 8.33; 95% CI: 3.85
to 20.0; P <0.001; I2: 0%) (Fig. 3C).
DISCUSSION
The present study, which used rec-
ommended methods for systematic
reviews and meta-analyses, aimed to
compare effectiveness of different
vertical ridge augmentation pro-
cedures and then compare these pro-
cedures with treatment alternatives.
However, due to the lack of data on
many therapeutic approaches, the
only comparison that could be made
was between alveolar ridge augmen-
tation and short implants or inferior
alveolar nerve transposition.
Four trials involving atrophic
posterior mandibles with a residual
bone height of 5 to 8 mm evaluated
whether short implants could be an
alternative to inlay augmentation
with xenograft blocks in combination
with the placement of standard-
length implants (‡10 mm).24-27
Meta-analysis of these papers
showed short implant groups were
associated with significantly fewer
postoperative complications,
without compromising implant and
prosthetic survival (Fig. 3).24-27
However, these results should be
treated with caution since all four
trials had a potential risk of bias. In
addition, they were all conducted by
the same research group, using
a similar augmentation protocol, and
with limited follow-up and sample
sizes. What is more, their internal
validity might be compromised since
they were all conducted mainly in
multiple private practices, and in two
of the studies, operations were not
performed by the same surgeon,
leading to potential operator-dependentT
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bias.26,27 This issue could affect reliability and quality of
the studies. In addition, the small number of participants
in all these studies might have led to a Type 2 error
(failure to reject a false null hypothesis). Indeed, if implant
failure is defined as the primary outcome and a 0.2 dif-
ference between groups is considered clinically signifi-
cant (as proposed by Felice et al.25), only one study had
a statistical power greater than 70%.27 Furthermore, due
to the small number of papers available for review, no
evaluation of publication bias (i.e., funnel plot) could be
made.47 Finally, all but one of the selected articles re-
ported on studies performed in Italy, so their external
validity would seem to be threatened as well.30 Another
possible limitation of the present paper is that gray lit-
erature and hand searching of related journals were not
included in the search strategy, so some studies might
have been neglected.
Pen˜arrocha-Oltra et al.31 described similar survival
and success rates for implant treatment in sites with
vertical bone defects involving autogenous onlay block
grafts or short dental implants, but the rate of com-
plications was significantly higher in the augmented
group (this article was excluded because of its retro-
spective design).
On the other hand, a recent meta-analysis of RCTs
showed no differences among the groups regarding
implant survival/success and complications.40 A pos-
sible explanation for this difference could be related to
the fact that none of the four articles selected for that
paper were considered in the present review: two tri-
als51,52 were replaced by others with more recent
data,24,25 one study included augmentation techniques
in the posterior maxilla,62 and one paper was rejected
because standard implants were placed in native
bone.63
Treatment duration and cost may also play an im-
portant role in the decision and willingness of the patient
to undergo vertical ridge augmentation.64 Undeniably,
bone regeneration techniques entail additional bi-
ologic and financial costs associated with one addi-
tional surgical procedure, a bone substitute, and
a barrier membrane, and at least an additional 4
months to complete treatment. In the studies re-
viewed, almost twice the number of patients preferred
short implants to augmentation procedures, although
the difference was not significant, probably due to the
small number of meta-analyzed studies reporting
patient-based outcomes.24,27
Figure 3.
Forest plots (OR) for implant failure (A), prosthetic failure (B), and postoperative complications (C) comparing short implants (test group) with
interpositional block xenografts covered with a resorbable membrane to receive long implants (control group) at 12 months’ follow-up. IV = independent
variable.
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Several reports show implant length has no impact
on peri-implant MBL in the short term.65-67 However,
it seems reasonable to assume that peri-implant bone
loss around short implants can be more critical than
in standard implants, as loss of osseointegration can
occur in a short time span.65 Therefore, it is crucial to
control main risk factors for peri-implant diseases
and apply strict maintenance programs for long-term
performance of these implants.
Information on inferior alveolar nerve transposition
is scarce, highlighting the need to perform RCTs to
assess whether this approach offers advantages over
other surgical techniques in the posterior area of the
mandible. Thus, in the opinion of the authors, until
data from well-designed RCTs become available for
analysis, other options such as use of short implants
or augmentation techniques seem preferable.
Although 10 of the trials included aimed to de-
termine the most effective vertical bone augmentation
techniques, a meta-analysis could not be performed
since there were insufficient trials comparing the same
interventions.3,11-13,19,20,28-30,34
Vertical augmentation techniques evaluated showed
some failures3,11,20,24,26-30,34 and were associated with
high complication rates, ranging from 8%13 to 90%.26
Furthermore, it has to be taken into account that since
most grafting procedures were performed by experi-
enced clinicians, caution is recommended when ex-
trapolating results to other clinical scenarios such as
general practice.
Distraction osteogenesis allows more bone gain19
and a reduction in treatment time.3,19,20 However,
other procedures such as GBR or onlay block grafting
techniques may permit simultaneous bone widening
if needed.5
Autogenous bone is often considered the ‘‘gold
standard’’ material for bone augmentation procedures.5
Nevertheless, three trials compared autogenous grafts
with bone substitutes and observed no differences for
any clinical outcomes registered.12,28,30 Indeed, Felice
et al.28 reported eight out of 10 patients preferred
augmentation procedures with a bone substitute,
probably due to lower postoperative morbidity. On the
other hand, from a histomorphometric point of view,
two of the studies revealed more residual grafted
material at implant placement in the group treated with
bone substitutes.28,30 Moreover, implants placed in
bone augmentedwith substitutes showed a tendency to
increased MBL.12,28 Further research is needed to
clarify which graft material is most cost-effective.
Similarly, non-resorbable titanium-reinforced ex-
panded polytetrafluoroethylene (ePTFE) membranes
are traditionally considered the benchmark for ver-
tical GBR.8,9,68,69 However, an increased rate of soft
tissue complications after premature membrane ex-
posure has been reported as a major disadvantage of
these barriers.70 Once exposed to the oral cavity, their
porous surface (100- to 300-mm porosity)13 is rapidly
colonized by bacteria, leading to infections of adjacent
tissues that require early membrane removal, result-
ing in impaired bone regeneration.71,72 Another dis-
advantage of non-resorbable membranes is the need
for re-entry surgery and membrane removal, which is
associated with patient morbidity. To overcome such
drawbacks and simplify surgical protocols, resorbable
membranes have been proposed.73 Merli et al.11 re-
vealed similar outcomes with fewer postoperative
complications when using resorbable barriers in
comparison with non-resorbable ones after a 6-year
follow-up period. Nevertheless, when ePTFE was
used, a higher bone gain was recorded, and less peri-
implant MBL was registered over time.
CONCLUSIONS
Placement of short implants (5 to 8 mm) seems to be
the best option for treating atrophic posterior areas of
the mandible, since this approach is less invasive and
has a significantly lower complication rate when
compared with more demanding grafting procedures.
Furthermore, survival rates and marginal bone level
changes after 1 year of loading seem similar. To confirm
these results, large-sample studies involving several
centers and countries, different surgical protocols, and
patient-centered outcomes should be conducted.
Different surgical protocols for vertical bone aug-
mentation seem to provide similar intergroup results.
Bone substitutes usually entail less postoperative mor-
bidity andmaybe a valid alternative to autogenous bone.
Well-designed RCTs are needed to determine which
bone augmentation techniques are more effective,
simpler, and safer and have better long-term results.
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